Dosage Forms & Drug Delivery Systems – Page 27

Ph Drift during method transfer: packaging integrity and CCIT justification

The first step in addressing pH drift during method transfer is to identify and document any symptoms that could indicate underlying issues. Symptoms may arise during routine testing, stability studies,…

Residual Solvent Oos during EU/UK market supply: packaging integrity and shelf-life justification

Identifying symptoms or signals indicative of residual solvent OOS is critical for prompt action. Common signals may include:Click to read the full article.

Dose Delivery Variability during die-cutting: inspection-ready documentation pack

Symptoms of dose delivery variability can manifest on the manufacturing floor or during laboratory testing. Key indicators include:Click to read the full article.

Curling After Packaging during scale-up: process parameter review and validation impact

Identifying symptoms of curling in transdermal patches or similar dosage forms is crucial for initiating an investigation. Symptoms may include:Click to read the full article.

Sterility Test Failure during aseptic filling: FDA-ready investigation report and batch disposition

The initial indicators of a sterility test failure often arise from routine quality control (QC) inspections or batch release processes. Employees should remain vigilant for the following signals:Click to read…

Backing Delamination during scale-up: root cause mapping across materials and process

Identifying symptoms and signals associated with backing delamination is the first step in addressing this issue. Symptoms can emerge on the production floor or during laboratory evaluations. Common signs to…

Suppository Deformation after temperature excursion: packaging integrity and stability justification

Recognizing symptoms indicative of suppository deformation after a temperature excursion is essential for timely containment and investigation. Symptoms may manifest as follows:Click to read the full article.

Ccit Failure during aseptic filling: packaging integrity and CCIT justification

When CCIT failures occur, several key symptoms and signals can arise on the production floor or in the laboratory that indicate potential integrity issues:Click to read the full article.

Phase Separation at accelerated stability: packaging integrity and stability justification

When dealing with phase separation, several signals may indicate a problem within your manufacturing process or the final product:Click to read the full article.

Pet Failure at accelerated stability: process controls for moulding, filling, and storage

Identifying pet failure begins with recognizing specific symptoms in the laboratory or on the manufacturing floor. Such symptoms can manifest as deviations from expected moisture content, chemical stability, or visual…

Fill Weight Variability in suppository manufacturing: CAPA with effectiveness checks for auditors

Recognizing symptoms of fill weight variability is crucial for timely intervention. Below are common signals that manufacturing or quality control personnel may observe:Click to read the full article.

Em Excursion during routine EM trending: sampling, filtration, and EM controls

Identifying signs of an Em excursion is the first step in addressing the issue. Common symptoms may include:Click to read the full article.